{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:10:58Z","timestamp":1790964658725,"version":"4.1.0"},"reference-count":13,"publisher":"SAGE Publications","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ASSAY and Drug Development Technologies"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1089\/adt.2015.29014.ajkdrrr","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T16:27:30Z","timestamp":1450715250000},"page":"650-653","source":"Crossref","is-referenced-by-count":23,"title":["Repurposing and Rescuing of Mibefradil, an Antihypertensive, for Cancer: A Case Study"],"prefix":"10.1177","volume":"13","author":[{"given":"Andrew J.","family":"Krouse","sequence":"first","affiliation":[{"name":"Tau Therapeutics LLC, Charlottesville, Virginia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Gray","sequence":"additional","affiliation":[{"name":"Tau Therapeutics LLC, Charlottesville, Virginia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Macdonald","sequence":"additional","affiliation":[{"name":"Tau Therapeutics LLC, Charlottesville, Virginia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McCray","sequence":"additional","affiliation":[{"name":"Tau Therapeutics LLC, Charlottesville, Virginia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3681"},{"issue":"11","key":"B2","volume":"08","author":"Herper M","year":"2013","journal-title":"Forbes"},{"key":"B3","volume-title":"Spring","volume":"11","author":"Persidis A","year":"2012"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.85.339"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2004.05.001"},{"key":"B6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0022-3565(24)38902-5","volume":"295","author":"Martin RL","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1586\/era.13.34"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-012-0995-0"},{"issue":"1","key":"B9","first-page":"Abstract","volume":"73","author":"Casarez EV","year":"2013","journal-title":"Cancer Res"},{"issue":"1","key":"B10","first-page":"Abstract","volume":"72","author":"Pottle J","year":"2012","journal-title":"Cancer Res"},{"key":"B11","first-page":"25","volume":"14","author":"Xu Z","year":"2012","journal-title":"Neuro-Oncology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2012-LB-262"},{"key":"B13","doi-asserted-by":"crossref","first-page":"TPS2105","DOI":"10.1200\/jco.2013.31.15_suppl.tps2105","volume":"31","author":"Holdhoff M","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["ASSAY and Drug Development Technologies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.liebertpub.com\/doi\/pdf\/10.1089\/adt.2015.29014.ajkdrrr","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:20:21Z","timestamp":1777393221000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/adt.2015.29014.ajkdrrr"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1089\/adt.2015.29014.ajkdrrr"],"URL":"https:\/\/doi.org\/10.1089\/adt.2015.29014.ajkdrrr","relation":{},"ISSN":["1540-658X","1557-8127"],"issn-type":[{"value":"1540-658X","type":"print"},{"value":"1557-8127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}